Reconstitution of Powdered Triamcinolone for Subacromial Injection
For subacromial shoulder injection, use triamcinolone acetonide 40 mg without reconstitution if using a pre-mixed suspension, or if you have powdered triamcinolone, reconstitute it with sterile normal saline or sterile water for injection to achieve a final concentration of 40 mg/mL, then inject the appropriate volume (typically 1 mL = 40 mg total dose) into the subacromial space. 1
Understanding the Product Form
Most triamcinolone acetonide products come as pre-mixed suspensions rather than true powders requiring reconstitution. 2 The vial contains a suspension that has settled and appears as white precipitate, which is normal. 2
Critical Pre-Injection Steps
- Shake the vial vigorously before withdrawing to ensure uniform suspension of the medication. 2
- Inspect for agglomeration (clumping or granular appearance with white precipitate separated from solution) - if present, discard the vial and do not use it. 2
- Inject immediately after withdrawal to prevent settling in the syringe. 2
Dosing for Subacromial Injection
The standard dose is 40 mg of triamcinolone acetonide for shoulder injections, whether targeting the subacromial space or glenohumeral joint. 1 This translates to 1 mL if using a 40 mg/mL concentration.
If True Reconstitution Is Required
If you genuinely have a powdered form (rare for triamcinolone acetonide):
- Reconstitute with sterile normal saline to achieve 40 mg/mL concentration. 1
- For example, if you have 40 mg powder, add 1 mL sterile normal saline.
- Mix thoroughly until completely dissolved.
- Use immediately after reconstitution.
Dilution for Lower Concentrations (Not Typically Needed for Shoulder)
While not standard for subacromial injection, triamcinolone can be diluted with sterile normal saline for other indications:
Administration Technique
- Use strict aseptic technique - this is mandatory. 2
- For intramuscular or deep injections, use a minimum 1½ inch needle in adults; longer needles may be required in obese patients. 2
- Inject deeply into the intended space (subacromial bursa or joint). 2
- Avoid injecting into surrounding tissues, as this can cause tissue atrophy. 2
Critical Pitfalls to Avoid
- Never inject if agglomeration is present - the separated white precipitate indicates the product is unusable. 2
- Do not inject into sites with active infection (impetigo, herpes, cellulitis). 1
- Avoid injecting into the tendon substance itself - target the bursa or joint space, not the rotator cuff tendon. 2
- Do not delay injection after drawing up - the suspension will settle in the syringe. 2
Expected Duration of Effect
A single injection is often sufficient for acute conditions, though the evidence for long-term pain reduction in shoulder pathology is not well established. 1 Repeat injections may be considered if symptoms recur, typically spaced at least 3-4 weeks apart. 1